TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.

Daniel D Karp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.